I am currently growing 4 plants at a time, I plan on storing some of what I like and giving the rest away to family members that are regular smokers. Ultimately I am looking for a very low THC w/ a higher CBD so most of my family probably wont be all that interested in any of those left overs LoL.
I still have 8 Femmed seeds from Attitude so I wont need any for a little bit
Thanks Brick-Top, not that U care but Snatch is in my top 5 favorites
If you are looking for lower THC levels and high CBD levels you might want to read what is below and possibly see if you can find out what strains are among those with the properties you want/need. I have to believe if you contacted the Harborside Health Center they would tell you what some strains are.
Following is a press release from Harborside Health Center in support of a low-psychoactivity cannabis choice for people who may enjoy the non-psychoactive effects of cannabis.
Source:
http://www.redorbit.com/news/health/1847554/medical_cannabis_first_unveiling_of_new_strain_to_redefine_the/index.html?source=r_health
OAKLAND, Calif., April 8 /PRNewswire/ --
The availability of a new type of medical cannabis strain will be presented for the first time by Steve DeAngelo, who has been featured on CNN, The Wall Street Journal, Fortune Magazine, and The New York Times as Executive Director of one of the nation's top model and non-profit medical cannabis dispensaries, Harborside Health Center in Oakland, California. DeAngelo will announce the availability of this type of non-psychoactive cannabis that has been lab tested with California strains with CBD (Cannabidol) at the 6th Annual National Clinical Conference on Cannabis Therapeutics on Friday, April 16th at 12PM Noon at The Crown Plaza Hotel, 801 Greenwich Avenue, Warwick, Rhode Island. DeAngelo is a leading national advocate and recognized expert for medical cannabis. Conference information can be found at
http://www.medicalcannabis.com
For three decades, DeAngelo has been an engaging speaker as he cuts through the stigma, and delivers the true facts about cannabis. His exciting and important presentation will include results of the first large scale analytical study of California's medical cannabis supply, which revealed that one of the most medically efficacious cannabinoids--CBD--has been bred out of plants grown primarily for psychoactive effect. Only within the past year have CBD-rich cannabis varieties been identified, thanks to an analytical chemistry lab that DeAngelo helped launch.
Recent research has demonstrated that CBD is effective in slowing or reversing a number of different types of cancer; as well as other serious illnesses. In response to the shortage of CBD rich cannabis varieties, Harborside has initiated a program to identify such strains, and encourage growers to propagate them. Because CBD modulates the psycho activity of THC, some patients respond better to varieties of cannabis which couple low THC levels with high CBD levels, because they enhance medical efficacy while reducing or eliminating psycho activity. This is particularly true for cannabis-naive patients, who have no prior experience with it, prior to receiving a recommendation from their doctor.
"Ultimately, there will be greater demand for CBD-rich cannabis, than there is for cannabis that just gets you high," predicts DeAngelo. "Only a small percentage of people enjoy the psycho activity of cannabis, but almost everybody can benefit from its medical properties".
